FDA Clears AI Tool for Breast Cancer Recurrence Risk Assessment via MRI
The U.S. Food and Drug Administration has granted clearance to a software tool designed to evaluate breast cancer recurrence risk through magnetic resonance imaging. The tool leverages artificial intelligence to analyze MRI data, offering clinicians an additional resource for treatment decision-making.
Medical imaging AI continues to expand its